Sterling Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.69K Sell
2,115
-1,783
-46% -$3.35K ﹤0.01% 2923
2025
Q4
$9.32K Sell
3,898
-769
-16% -$2.1K ﹤0.01% 2638
2025
Q3
$13.3K Buy
4,667
+2,841
+156% +$9.72K ﹤0.01% 2338
2025
Q2
$6.88K Buy
1,826
+880
+93% +$3.46K ﹤0.01% 2341
2025
Q1
$4.29K Sell
946
-764
-45% -$4.04K ﹤0.01% 2245
2024
Q4
$12.1K Buy
1,710
+1,520
+800% +$12.1K ﹤0.01% 2081
2024
Q3
$1.55K Buy
+190
New +$1.37K ﹤0.01% 2315

Other funds holding HCAT

Sterling Capital Management's HCAT Position: Q1 2026 in Review

Sterling Capital Management reduced its Health Catalyst (HCAT) stake by 46% in Q1 2026, selling an estimated $3.35K and leaving 2,115 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2923.

Sterling Capital Management first reported a position in HCAT in Q3 2024 and has held it in 7 quarters since. The position peaked at $13.3K in Q3 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Sterling Capital Management held 2,115 shares of Health Catalyst worth $2.69K as of Q1 2026.
  • Sterling Capital Management sold 1,783 Health Catalyst shares in Q1 2026, an estimated $3.35K.
  • Health Catalyst made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2923 holding.
  • Sterling Capital Management first reported a position in Health Catalyst in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Health Catalyst position peaked at $13.3K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.